Current approaches to monitoring and management of heart failure

Clyde W. Yancy*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Decompensation in patients with congestive heart failure remains a treatment problem. Earlier detection of decompensation may result in a lessened need for hospitalization and perhaps an interruption of the as-yet-undetermined processes during decompensation that lead to an adverse effect on the natural history of heart failure. B-type natriuretic peptide is produced by right and/or left ventricular tissue in response to an increase in ventricular wall stress and may be used as an indicator of decompensation. New directions in monitoring now include novel device-based algorithms that determine either intraventricular pressure or intrathoracic impedance. When combined with clinical assessment, weight monitoring, and symptom assessment, these newer monitoring platforms may yield improvements in the natural history of heart failure.

Original languageEnglish (US)
JournalReviews in Cardiovascular Medicine
Issue numberSUPPL. 1
StatePublished - Oct 3 2006


  • B-type natriuretic peptide
  • Congestive heart failure
  • Decompensation
  • Heart failure monitoring

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Current approaches to monitoring and management of heart failure'. Together they form a unique fingerprint.

Cite this